Search
FORGEN II IS3 Develpment and production of recombinant live vaccines based on a new Escherichia coli carrier system
FORGEN II IS3 Develpment and production of recombinant live vaccines based on a new Escherichia coli carrier system Aim of the Project:Development of new live vaccines consisting of the benevolent…
FORGEN II IS2 Safety and efficiency of recombinant bacterial live vaccines in immuno competent and immuno deficient mice.
FORGEN II IS2 Safety and efficiency of recombinant bacterial live vaccines in immuno competent and immuno deficient mice. The progress in molecular biology of pathogenic bacteria and advances in…
FORGEN II IS1 Development of newly designed recombinant live attenuated bacterial vaccine strains. Presentation of heterologous antigens by the plasmid-encoded type III secretion - translocation system of Yersinia enterocolitica
FORGEN II IS1 Development of newly designed recombinant live attenuated bacterial vaccine strains. Presentation of heterologous antigens by the plasmid-encoded type III secretion - translocation…
FORGEN
RESEARCH NETWORK FOR FUNDAMENTAL GENETIC TECHNOLOGY
I4 - Replicon-Technology for Assessment and Production of Adenoviruses with a High Security Profile
I4 - Replicon-Technology for Assessment and Production of Adenoviruses with a High Security Profile Based on a newly developed replicon vector system for the complementation of herpesviruses, a…
I3 - Development of Immunological Assays for Immunomonitoring in the Context of a Viral Vaccination Platform
I3 - Development of Immunological Assays for Immunomonitoring in the Context of a Viral Vaccination Platform The company AmVac Research GmbH provides a vector platformbased on a replication…
I2 - Characterization of Immunological Biomarkers During Antiviral Therapy by Use of Cellular Targets
I2 - Characterization of Immunological Biomarkers During Antiviral Therapy by Use of Cellular Targets The long term aim of this project is the identification and characterization of…
I1 - Identification of Key Positions in Virus-Specific Cellular Signaling as Markers for Therapy, Immunity and Diagnostics
I1 - Identification of Key Positions in Virus-Specific Cellular Signaling as Markers for Therapy, Immunity and Diagnostics Viruses are subject to various regulatory interactions with their host …
D7 - Development of a Koff-Rate Assay for Diagnostic Application
D7 - Development of a Koff-Rate Assay for Diagnostic Application T cells with high avidity for their cognate ligand are believed to be most effective in clearing viral infections or inducing tumor …
D6 - T-Cell Diagnostics for Individualized Therapy Following Transplantation
D6 - T-Cell Diagnostics for Individualized Therapy Following Transplantation The monitoring of the immunosuppression is an important part in the follow-up of patients after transplantations. The…